Oncternal Therapeutics (ONCT)
(Delayed Data from NSDQ)
$5.75 USD
-0.75 (-11.54%)
Updated Aug 2, 2024 02:03 PM ET
After-Market: $6.05 +0.30 (5.22%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: AMC |
6/2024 | $-3.03 | 0.00% |
Earnings Summary
For their last quarter, Oncternal Therapeutics (ONCT) reported earnings of -$2.83 per share, beating the Zacks Consensus Estimate of $-2.88 per share. This reflects a positive earnings surprise of 1.74%. Look out for ONCT's next earnings release on August 08, 2024. For the next earning release, we expect the company to report earnings of -$3.03 per share, reflecting a year-over-year decrease of 1%.
Earnings History
Price & Consensus
Zacks News for ONCT
All You Need to Know About Oncternal Therapeutics (ONCT) Rating Upgrade to Buy
ONCT: What are Zacks experts saying now?
Zacks Private Portfolio Services